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Calcium-imaging techniques were used to determine if mouse retinal astrocytes in situ respond to agonists of ionotropic
(𝛼-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, AMPA; N-methyl-D-aspartate, NMDA) and metabotropic (S-3,5-
dihydroxyphenylglycine, DHPG; trans-1-amino-1,3-cyclopentanedicarboxylic acid, ACPD) glutamate receptors. In most cases we
found no evidence that retinal astrocyte intracellular calcium ion concentration ([Ca2+]i) increased in response to these glutamate
agonists.The one exception was AMPA that increased [Ca2+]i in some, but not all, mouse retinal astrocytes in situ. However, AMPA
did not increase [Ca2+]i in mouse retinal astrocytes in vitro, suggesting that the effect of AMPA in situmay be indirect.
1. Introduction
Historically astrocytes were regarded as structural compo-
nents of the nervous system parenchyma, with few functional
attributes. This view changed when astrocytes in vitro and in
situ were found to possess receptors for many neurotrans-
mitters including glutamate, adenosine, 𝛾-aminobutyric acid
(GABA), and epinephrine (for review see [1–3]). Activation
of astrocyte neurotransmitter receptors commonly results
in an increase in cytosolic calcium concentration ([Ca2+]i)
that could lead to calcium-dependent release of chemical
transmitters, termed gliotransmitters (for review see [4]).
The effect of glutamate, the predominant excitatory neu-
rotransmitter in the CNS, on astrocytes has been well docu-
mented in the brain. Early experiments using acutely isolated
hippocampal astrocyte cultures showed that application of
glutamate resulted in an initial spike-like rise in [Ca2+]i
followed by a sustained [Ca2+]i increase [5]. Further, astro-
cytes in hippocampal slices showed increased [Ca2+]i follow-
ing exposure to glutamate released from Shaffer collaterals
upon stimulation [6, 7]. Astrocyte activation and calcium
mobilization caused by glutamate lead to the subsequent
release of gliotransmitters, such as adenosine triphosphate
(ATP) and D-serine [8, 9]. Numerous studies have revealed
that both metabotropic and ionotropic glutamate receptors
are expressed by brain astrocytes and that activation of
these receptors commonly results in measureable increases
in [Ca2+]i [1, 7, 9–12].
There are two types of macroglia in the mammalian
retina: astrocytes and Müller cells. Anatomically, astrocytes
are confined to the nerve fibre layer (NFL), whereas Müller
cells run radially from the vitreal surface, or the inner limiting
membrane, to the outer limiting membrane. Several studies
have suggested thatMüller cells are involved in neurovascular
coupling mediated by ATP, both as the recipient of the
neuron-to-glia signal and as the source of ATP released from
glia onto retinal vessels [13–16].
Glutamate is the primary excitatory neurotransmitter
in the retina and, therefore, could potentially contribute
to neuronal-glia signalling in the retina. Müller cells in
some [17, 18] but not all [19] types of vertebrate retinas
show increased [Ca2+]i in response to glutamate or gluta-
mate receptor agonists. It is not clear if retinal astrocytes
respond to glutamate and if such responses involve an
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increase in [Ca2+]i. A study of rabbit retinal astrocytes in situ
[20] demonstrated that glutamate and𝛼-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) agonists evoked
inward currents. Glutamate-evoked currents were blocked by
the AMPA/kainate ionotropic glutamate receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). N-Methyl-
D-aspartate (NMDA) did not evoke currents in these astro-
cytes [20]. In contrast, when applied to rat retinal astrocytes
in situ, glutamate did not evoke [Ca2+]i increases [19].
In the present study we used calcium-imaging techniques
to determine if mouse retinal astrocytes in situ respond to
agonists of ionotropic andmetabotropic glutamate receptors.
In most cases we find no evidence to suggest that retinal
astrocytes are responsive to glutamate agonists. The one
exception was AMPA that increased [Ca2+]i in some, but
not all, mouse retinal astrocytes in situ. However, AMPA
did not increase [Ca2+]i in mouse retinal astrocytes in vitro,
suggesting that the action of AMPA in situmay be indirect.
2. Materials and Methods
The Dalhousie University Committee on Laboratory Ani-
mals (UCLA) approved all protocols, and procedures were
performed in accord with regulations established by the
Canadian Council on Animal Care (CCAC). All chemicals
were obtained from Sigma-Aldrich (Oakville, ON, Canada)
unless stated otherwise.
2.1. Animals and Husbandry. C57BL/6 mice were purchased
from Charles River (St. Constant, Quebec, Canada) and
housed at the Carleton Animal Care Facility in the Tupper
Medical building at Dalhousie University. Animals were kept
in cages with up to four other mice and had access to food
and water ad libitum.
2.2. Tissue Preparation. Animals were sacrificed by a lethal
intraperitoneal injection of sodium pentobarbital (CDMV,
Dartmouth, NS, Canada). Upon confirmation of death, the
animal’s eyes were removed quickly and placed in room
temperature Hanks’ Balanced Salt Solution (HBSS) bubbled
with 100% oxygen and proton buffered with 10mM HEPES
(pH 7.4). Astrocytes in situ were loaded with calcium dye by
electroporation. Calcium indicator dye (750 nL of a 20mM
fura-2 pentapotassium salt solution; Invitrogen, Burlington,
ON, Canada) was injected into the eye through the optic disk
using a Hamilton syringe. Tweezertrodes (BTX, Holliston,
MA, USA) were positioned on the eye with the anode on
the cornea and square wave current pulses were applied
using the ECM 830 electroporation system (BTX). The eyes
were electroporated with five square 20ms current pulses
of 30V at 1Hz. Retinas were isolated by careful dissection
and the vitreous humour removed by gentle tweezing with
forceps. Retinas were flat mounted on black filter paper
(Millipore) with the vitreal surface facing up, secured in place
with a platinum ring, and maintained for 10–15 minutes in
oxygenated HBSS prior to being transferred to a microscope-
mounted superfusion chamber for calcium imaging.
2.3. Preparation of Isolated Retinal Astrocyte Cultures. Iso-
lated retinas from 2-3 C57BL/6 mice (Charles River) were
added to 5mL Mg2+- and Ca2+-free Dulbecco’s Phosphate
Buffered Saline (DPBS; Invitrogen) containing 56𝜇L papain
(16.5 units/mL, 29.4 units/mg of protein; Worthington) and
50 𝜇L 0.004% DNase (Worthington). Retinas were incubated
in this solution at 37∘C for 30min. Following incubation,
the papain solution was aspirated from the retinas. Next,
400 𝜇L of media composed of 45mL Dulbecco’s Modified
Eagle Medium (DMEM; Invitrogen), 5mL Fetal Bovine
Serum (FBS; Hemoglobin ≤ 20mg/dL), and 100 𝜇L Penicillin
Streptomycin (Pen/Strep, 10,000 units/mL; Invitrogen), here-
after simply referred to as media, was added, and retinas
were gently triturated. Glass coverslips (12mm) were washed
overnight in 70% ethanol on a shaker. The next morning,
they were rinsed three times in distilled water and autoclaved
for 20min. Autoclaved coverslips were placed in Nunc 4-
well plates and coated with Poly-D-Lysine (PDL; 10𝜇g/𝜇L)
for one hr and then rinsed three times in distilled water. Cells
were plated on the prepared coverslips and stored in wells
containing media in an incubator at 37∘C for at least 14 days
to allow cells to grow. Media were changed every 2-3 days.
For calcium imaging individual coverslips were incubated in
5 𝜇M fura-2-acetoxymethyl ester (AM; Invitrogen) dissolved
in 100% oxygenated HBSS (10mM HEPES, pH 7.4, 1 𝜇g/mL
pluronic acid) for one hour before being transferred to a
superfusion chamber mounted on a microscope.
2.4. Calcium Imaging. Single retinas or coverslips containing
cultured retinal astrocytes were placed in a superfusion
chamber (∼750𝜇L volume) and superfused with 100% oxy-
genatedHBSS (10mMHEPES, pH7.4) at a rate of∼2mL/min.
Retinas were imaged with a charge-coupled device (CCD)
camera (Sensicam, PCO, Germany) connected to a Zeiss
Axioskop microscope equipped with a 40x water immersion
objective and recorded using Axon Imaging Workbench 4
software (Molecular Devices, Sunnyvale, CA, USA). Images
were typically acquired at a frequency of one frame per 20 sec,
increased to one frame per 5 sec during periods of drug
applications. Ratiometric fura-2 dyes (𝐾
𝑑
= 224 nM) were
used, and image pairs at 340 and 380 nm excitation (510 nm
emission) were collected.
2.5. Experimental Protocol. In whole mount retinas, astro-
cytes loaded with fura-2 were identified based on stereotypi-
cal morphological characteristics [19], including a flattened
cell body with a series of radiating processes, forming a
layer, positioned within the nerve fibre layer, that can be
identified in whole mount preparations as just superficial
(vitreal) to neurons (also loaded somewhat with fura-2)
in the ganglion cell layer, and (frequently, but not always)
forming perivascular endfeet on retinal blood vessels. The
effect of ionotropic glutamate receptor agonist on astro-
cyte calcium levels was tested by exposing astrocytes to
ionotropic glutamate receptor agonists (10 𝜇M AMPA or
50 𝜇M NMDA), the general metabotropic glutamate recep-
tor agonist trans-1-amino-1,3-cyclopentanedicarboxylic acid
monohydrate (ACPD, at 50 𝜇M), or the group Imetabotropic
agonist (S)-3,5-dihydroxyphenylglycine (DHPG, at 50 𝜇M)
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Figure 1: Photomicrographs illustrating loading of astrocytes with fura-2 and imaged at 380 nm excitation and 510 nm emission. (a)
Astrocytes in the retinal whole mount preparation (in situ) loaded with fura-2 by electroporation. Numerous astrocytes are loaded; some
examples are highlighted within boxes. A blood vessel can been seen with fura-2-loaded presumptive perivascular endfeet (arrows). (b)
Astrocytes in vitro loaded with fura-2. Scale bar (for both (a) and (b)) 50𝜇m.
dissolved in the superfusate solution, for 30 sec. Each prepa-
ration was treated with one agonist two to four times. To
assess cell viability, and to contrast responses to the effect
of the glutamate agonists, the calcium response induced by
10 𝜇MATP was also tested in most astrocytes studied.
2.6. Data Analysis. Using Axon ImagingWorkbench (AIW),
identified astrocytes were circled post hoc as a region of inter-
est (ROI). The software provided measures of fluorescence
ratiowith respect to time for eachROI. Statistical analysis was
conducted using Prism 6 (GraphPad, La Jolla, CA, USA).
Baseline ratios were analyzed to assess fluctuations
(noise) over 3min periods prior to agonist treatments.
Agonist-induced calcium dynamics were determined as the
peak change (Δ𝑓) from baseline (𝑓) during a 3min period
following the onset of a 30 s agonist application. Peak Δ𝑓
for each agonist application was averaged for each cell, and
averages for each cell were used to calculate themean peakΔ𝑓
of each retina or coverslip. For each conditionmean baseline,
agonist- and ATP-induced Δ𝑓 values were compared using
the Kruskal-Wallis test andDunn’smultiple comparisons test.
3. Results
3.1. Loading Astrocytes with Calcium Indicator Dye. Elec-
troporation has proven an effective means to load retinal
neurons in situ with calcium indicator dye [21–24]. We made
the serendipitous discovery that by reversing the polarity
of the electroporation electrodes on the eye (placing the
anode on the anterior pole and the cathode on the posterior
pole) there was strong loading of astrocytes with calcium
indicator dye (Figure 1(a)). Astrocytes loaded with dye (in
this case fura-2) were identified based on stereotypical
morphological characteristics [19] including a flattened cell
body with a series of radiating processes, forming a layer,
positioned within the NFL, that can be identified in whole
mount preparations near to blood vessels with perivascular
endfeet contacts on retinal blood vessels. Isolated astrocytes
were loaded with fura-2 by conventional means (incubation
in solution containing membrane-permeable fura-2 AM;
Figure 1(b)).
3.2. Effect of AMPA and NMDA on [Ca2+]i in Retinal
Astrocytes In Situ. Bath application of 10 𝜇M AMPA elicited
an increase of fura-2 fluorescence ratio in many but not all
mouse retinal astrocytes studied in situ. Figure 2(a) shows
a trace from a representative astrocyte treated twice with
10 𝜇MAMPA and, at the conclusion of the experiment, 10 𝜇M
ATP. The response to ATP was robust whereas the response
to AMPA was smaller, but discernable. Mean data from all
astrocytes studied in 5 different retinas (139 astrocytes) are
illustrated in Figure 2(b). Although the mean peak response
to both AMPA and ATP was increased relative to baseline
(a measure of the fluctuations over 3min prior to agonist
treatment), and the results of theKruskal-Wallis test indicated
that there was a significant difference in mean peak Δ𝑓
(baseline, AMPA- and ATP-treated; 𝐻 = 11.58; 𝑝 < 0.0001
at 𝛼 = 0.05), Dunn’s multiple comparison tests revealed
that there was only a significant difference between baseline
and the mean peak response to ATP (Figure 2(b)). Another
way to assess this data [10, 25] is to consider how many
astrocytes responded to treatment, defined by reaching a
minimum increase of calcium dye fluorescence signal. We
defined a responding cell as one that showed an increase in
fura-2 fluorescence ratio ≥ 0.02 from mean baseline during
treatment (and this exceeded 2 standard deviations associated
with mean baseline fluorescence). 45% of all astrocytes stud-
ied showed an increase (Δ𝑓) of fura-2 fluorescence ratio ≥
0.02 in response to 10 𝜇MAMPA. All cells (100%) responded
to 10 𝜇MATP.Thenumber of cells that responded (Δ𝑓 ≥ 0.02)
to ATP but not AMPA (55% of all cells studied) limits the
comparison of the mean data. That a significant number of
cells (45% of all cells studied) responded to AMPA suggests
that at least some astrocytes show increases in [Ca2+]i in
response to AMPA application in situ.
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Figure 2: Effect of ionotropic glutamate receptor agonists AMPA and NMDA on retinal astrocytes [Ca2+]i in situ. (a) Representative trace
showing fura-2 fluorescence ratio of an astrocyte treated twice with 10𝜇MAMPA followed by 10𝜇MATP.The astrocyte showed a small, but
discernable, response to both treatments with 10 𝜇M AMPA and a larger response to 10 𝜇M ATP. (b) The mean response elicited by AMPA
was not significantly different from baseline, but the mean response elicited by ATP was. (c) Representative trace showing fura-2 fluorescence
ratio of an astrocyte treated twice with 10𝜇M NMDA followed by 10𝜇M ATP. The astrocyte responded to ATP, but not NMDA. (d) Mean
response elicited by NMDA application was not significantly different from baseline, while mean response elicited by ATP was. Responses are
reported as the average peak change (Δ𝑓) from baseline (𝑓) during a 3min period following 30 s agonist applications. Error bars are SEM, 𝑛
= number of retinas studied, ns: not significant; ∗∗𝑝 < 0.01 at 𝛼 = 0.05 as determined by Dunn’s multiple comparisons test following Kruskal
Wallis ANOVA.
Bath applications of 50 𝜇MNMDA typically did not elicit
a response frommouse retinal astrocytes in situ (Figures 2(c)
and 2(d)). Figure 2(c) shows a trace from a representative
cell treated twice with 50𝜇M NMDA and then 10 𝜇M ATP.
The mean peak Δ𝑓measured from the 5 retinas studied (179
astrocytes) during NMDA treatment was indistinguishable
from baseline (Figure 2(d)). The Kruskal-Wallis test revealed
that there was a significant difference between mean peak
Δ𝑓 (baseline, NMDA-, and ATP-treated; 𝐻 = 9.620, 𝑝 =
0.0018), but this difference was due solely to the effect of
ATP (Dunn’s multiple comparisons test; Figure 2(d)). Of the
179 astrocytes studied, only 3 cells (2%) showed an increase
in fura-2 fluorescence ratio of ≥0.02 during treatment with
50𝜇MNMDA. All cells (100%) responded to 10 𝜇MATP.
3.3. Effect of DHPG and ACPD on [Ca2+]i in Retinal Astro-
cytes In Situ. Bath application of the group I metabotropic
glutamate receptor agonist DHPG (50 𝜇M) did not elicit a
significant response from mouse retinal astrocytes in situ
(Figures 3(a) and 3(b)). Figure 3(a) shows a trace from a
representative astrocyte treated twice with 50 𝜇M DHPG
followed by treatment with a single treatment with 10 𝜇M
ATP. ATP increased the ratio of fura-2 fluorescence but
DHPG had no effect. A similar result was found for mean
data from astrocytes studied in 5 different retinas (364 cells)
(Figure 3(b)). Statistical analysis (Figure 2(b)) indicated that
there was a significant difference between baseline and the
mean peak response to ATP (Kruskal-Wallis 𝐻 = 12.12, 𝑝 =
0.0023 followed by Dunn’s multiple comparison tests). Of the
364 astrocytes studied, only 8 cells (2%) showed an increase
in fura-2 fluorescence ratio of ≥0.02 during treatment with
50 𝜇MDHPG. All cells (100%) responded to 10 𝜇MATP.
Similarly, bath applications of the general metabotropic
glutamate receptor agonist ACPD (50 𝜇M) did not elicit a
significant response from mouse retinal astrocytes in situ
(Figures 3(c) and 3(d)). The Kruskal-Wallis test revealed that
there was a significant difference between mean peak Δ𝑓
(baseline, ACPD-, and ATP-treated; 𝐻 = 9.62, 𝑝 = 0.0081),
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Figure 3: Effect of metabotropic glutamate receptor agonists DHPG and ACPD on retinal astrocytes [Ca2+]i in situ. (a) Representative trace
showing fura-2 fluorescence ratio of an astrocyte treated twice with 50𝜇MDHPG followed by 10 𝜇M ATP. The astrocyte responded to ATP,
but not DHPG. (b)Themean response elicited by DHPGwas not significantly different from baseline, but the mean response elicited by ATP
was. (c) Representative trace showing fura-2 fluorescence ratio of an astrocyte treated twice with 50𝜇M ACPD followed by 10𝜇M ATP. The
astrocyte responded to ATP, but not ACPD. (d) Mean response elicited by ACPD application was not significantly different from baseline,
while mean response elicited by ATP was. Error bars are SEM, 𝑛 = number of retinas studied, ns: not significant; ∗∗𝑝 < 0.01 at 𝛼 = 0.05 as
determined by Dunn’s multiple comparison test following Kruskal-Wallis ANOVA.
but this difference was due solely to the effect of ATP (Dunn’s
multiple comparisons test; Figure 2(d)). Of the 179 astrocytes
studied, only 4 cells (2%) showed an increase in fura-2
fluorescence ratio of ≥0.02 during treatment with 50𝜇M
ACPD. All cells (100%) responded to 10 𝜇MATP.
3.4. Effect of AMPA and NMDA on Retinal Astrocytes In
Vitro. Thus far, the only glutamate receptor agonist that
produced an increase in fura-2 fluorescence ratio in situ (in
45% of cells tested) was AMPA. To determine if the effect
of AMPA in situ was due to a direct effect on astrocytes, we
tested the effect of AMPA (and also NMDA) on astrocytes in
vitro. Bath application of 10 𝜇MAMPA or 50𝜇MNMDA did
not elicit a significant response from isolated mouse retinal
astrocytes (Figure 4). Figures 4(a) and 4(c) show traces from
representative cells treated twice with AMPA or NMDA,
respectively, and then with 10 𝜇M ATP. In both cases ATP
increased the ratio of fura-2 fluorescence, but neither AMPA
nor NMDA had an effect. Statistical analysis of the mean
data revealed differences between baseline and the peakmean
Δ𝑓 response to ATP (Figure 4(b), Kruskal-Wallis 𝐻 = 8.769,
𝑝 = 0.0012; Figure 4(d), 𝐻 = 9.980; 𝑝 = 0.0009). The lack
of an effect of AMPA on astrocytes in vitro suggests that the
action of AMPA in situmay not be direct.
4. Discussion
The results of the present study provide evidence that mouse
retinal astrocyte [Ca2+]i, assessed by fura-2 imaging tech-
niques, is not increased by the ionotropic and metabotropic
glutamate receptor agonists NMDA, DHPG, and ACPD.
Mean peak fura-2 fluorescence ratios during agonist appli-
cations were not different than fluctuations observed under
baseline conditions.The one exception was AMPA. Although
the increase in peak mean fura-2 fluorescence ratio, com-
pared to baseline, was not statistically significant, about
half (45%) of all the cells studied showed an increase in
fluorescence of ≥0.02. (The number of such responding cells
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Figure 4: Effect of ionotropic glutamate receptor agonists AMPA and NMDA on retinal astrocytes [Ca2+]i in vitro. (a) Representative trace
showing fura-2 fluorescence ratio of an astrocyte treated twice with 10 𝜇M AMPA followed by 10𝜇M ATP. The astrocyte responded to ATP,
but not AMPA. (b)Themean response elicited by AMPAwas not significantly different from baseline, but the mean response elicited by ATP
was. (c) Representative trace showing fura-2 fluorescence ratio of an astrocyte treated twice with 10𝜇MNMDA followed by 10𝜇MATP. The
astrocyte responded to ATP, but not NMDA. (d) Mean response elicited by NMDA application was not significantly different from baseline,
while mean response elicited by ATP was. Error bars are SEM, 𝑛 = number of retinas studied, ns: not significant; ∗∗𝑝 < 0.01 at 𝛼 = 0.05 as
determined by Dunn’s multiple comparison test following Kruskal-Wallis ANOVA.
in the case of each of the other agonists was only 2%.)
We concluded, therefore, that AMPA increases [Ca2+]i in
response to AMPA application in situ. To determine if the
effect of AMPA was due to a direct effect on astrocytes, we
examined the effect of AMPA on astrocytes in vitro. AMPA
did not elicit a significant response from isolated mouse
retinal astrocytes suggesting that the effect of AMPA in situ
could be indirect.
Previous research has shown that astrocytes from the
brain not only express ionotropic glutamate receptors [1–3, 5–
7, 9–12] but also respond to ionotropic glutamate receptor
agonists, both in vitro and in situ, including AMPA and
NMDA [10, 26, 27]. In contrast, there are no studies exam-
ining the expression of glutamate receptor types expressed by
retinal astrocytes and only two studies that have examined
the effect of glutamate or AMPA/kainate glutamate receptor
agonists on retinal astrocytes. Clark andMobbs [20] reported
that glutamate and AMPA/kainate receptor agonists evoked
inward currents in rabbit retinal astrocytes in situ. This
same study showed that glutamate-induced inward currents
in retinal astrocytes were blocked by the AMPA/kainate
receptor antagonist CNQX. In contrast, Newman and Zahs
[19] reported that glutamate had no effect on rat retinal
astrocyte [Ca2+]i studied in situ, although glutamate did
potentiate increases of [Ca2+]i produced by other stimuli.Our
results are consistent with the results of Clark and Mobbs
[20] in that we were able to demonstrate an effect of AMPA
on mouse retinal astrocytes in situ. However, because AMPA
was without effect on mouse retinal astrocytes in vitro, it
is possible that the effect of AMPA in situ was indirect.
AMPA acting at retinal neurons or Müller cells could result
in transmitter, such as ATP or acetylcholine, release that, in
turn, could increase astrocyte [Ca2+]i [28–30].
We found that NMDA did not increase [Ca2+]i in
mouse retinal astrocytes in situ or in vitro. A common
concern when studying NMDA receptors is extracellular
Mg2+ block of the NMDA receptor [31]. Schipke et al. [27]
showed that NMDA-induced currents in mouse neocortical
astrocytes were enhanced in Mg2+-free conditions, reduced
at 4mMMg2+, and abolished at 10mMMg2+. However,
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the same study showed that NMDA-induced currents were
present, though of less magnitude, under standard recording
conditions (1.8mMMg2+). In fact, several studies have shown
that glial NMDA receptors are much less (or not) sensitive
to Mg2+ block [11, 32]. In our experiments, external Mg2+
was 0.8mM. Whether or not Mg2+ block is an issue in
mouse retinal astrocyteNMDA-dependent current or [Ca2+]i
increases deserves further investigation. Furthermore, the
NMDA-induced calcium dynamics reported by Schipke et
al. [27] were restricted to distal processes of the astrocytes
and were not observed in the cell bodies. The focus of the
present study was imaging of astrocyte somata, making it
possible that responses occurred in distal processes that were
not captured by our imaging.
Various types of ionotropic and metabotropic glutamate
receptors are present on astrocytes in many different brain
regions and, when activated, are often capable of increasing
[Ca2+]i (for review see [3]). That retinal astrocytes are
different adds to evidence that astrocytes in the CNS are het-
erogeneous [33, 34]. In fact, even though retinal astrocytes are
immigrants from the optic nerve [35], astrocytes in themouse
optic nerve show increases in [Ca2+]i in response to glutamate
and a variety of ionotropic and metabotropic agonists [30].
Although there was a small direct effect of glutamate, much
of the effect of glutamate on optic nerve astrocyte [Ca2+]i
was blocked by purinergic P2 receptor antagonists suggesting
that the effect of glutamate was mediated largely by an
indirect effect mediated by ATP [30]. Nonetheless, our data
suggest that the calcium responses of retinal and optic nerve
astrocytes to glutamate agonists are different, underlining the
heterogeneity of astrocytes in different regions of the CNS.
Perhaps this should not come as a surprise given that the
astrocytes studied in the optic nerve [30] were likely to have
been mostly type 1A or type 2 astrocytes whereas retinal
astrocytes are type 1B [36, 37].
Although our data suggest that glutamate is unlikely
to be an important direct activator of retinal astrocytes, at
least with respect to processes that would lead to elevated
[Ca2+]i, it was clear that ATP was a potent and consistent
elevator of [Ca2+]i in mouse retinal astrocytes. Although
the functional significance of elevated [Ca2+]i in astrocytes
remains controversial [38], it is possible that ATP-mediated
increases of [Ca2+]i in mouse retinal astrocytes are associated
with activity that regulates neuronal or vascular functions.
Although glutamate may not influence retinal astrocytes,
ATP is not necessarily the only endogenous agent capable
of increasing [Ca2+]i. As one example, we have preliminary
evidence that the potent vasoactive peptide, endothelin-1,
increases [Ca2+]i in rat retinal astrocytes in situ [39].
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